Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-02 Sale | 2023-03-06 8:46 pm | Sesen Bio Inc. | SESN | Sullivan Mark General Counsel & Secretary | 219,218 | $0.587 | $128,681 | 378,651 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 8:45 pm | Sesen Bio Inc. | SESN | MacDonald Glen C Chief Technology Officer | 170,372 | $0.587 | $100,008 | 398,918 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 8:44 pm | Sesen Bio Inc. | SESN | Ryu Elly Principal Accounting Officer | 17,289 | $0.587 | $10,149 | 148,624 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 8:43 pm | Sesen Bio Inc. | SESN | Cannell Thomas R President and CEO | 487,487 | $0.587 | $286,155 | 672,386 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 8:41 pm | Sesen Bio Inc. | SESN | Forbes Monica Chief Financial Officer | 345,849 | $0.587 | $203,013 | 505,664 (Direct) | View |
| 2023-02-21 Sale | 2023-02-23 7:38 pm | Sesen Bio Inc. | SESN | Sullivan Mark General Counsel & Secretary | 39,831 | $0.5873 | $23,393 | 299,694 (Direct) | View |
| 2023-02-21 Sale | 2023-02-23 7:36 pm | Sesen Bio Inc. | SESN | Ryu Elly Principal Accounting Officer | 7,159 | $0.5873 | $4,204 | 165,913 (Direct) | View |
| 2023-02-21 Sale | 2023-02-23 7:35 pm | Sesen Bio Inc. | SESN | Cannell Thomas R President and CEO | 53,727 | $0.5873 | $31,554 | 553,073 (Direct) | View |
| 2023-02-21 Sale | 2023-02-23 7:33 pm | Sesen Bio Inc. | SESN | Forbes Monica Chief Financial Officer | 61,862 | $0.5873 | $36,332 | 480,388 (Direct) | View |
| 2023-02-21 Sale | 2023-02-23 7:31 pm | Sesen Bio Inc. | SESN | MacDonald Glen C Chief Technology Officer | 25,927 | $0.5873 | $15,227 | 282,998 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Option Award | 2024-04-01 6:59 pm | N/A 2034-04-01 | Carisma Therapeutics Inc. | CARM | Hohneker John Director | 38,700 | $0 | 38,700 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:53 pm | N/A 2034-01-31 | Carisma Therapeutics Inc. | CARM | Morris Richard Steven Chief Financial Officer | 170,500 | $0 | 170,500 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:53 pm | N/A 2034-01-31 | Carisma Therapeutics Inc. | CARM | Klichinsky Michael Chief Scientific Officer | 170,500 | $0 | 170,500 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:52 pm | N/A 2034-01-31 | Carisma Therapeutics Inc. | CARM | Kelly Steven President and CEO | 438,000 | $0 | 438,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:20 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | Kelly Steven President and CEO | 600,000 | $0 | 600,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:19 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | ZWEIFACH SANFORD S Director | 38,700 | $0 | 38,700 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:18 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | Morris Richard Steven Chief Financial Officer | 238,000 | $0 | 238,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:16 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | Torok Michael Director | 38,700 | $0 | 38,700 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:15 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | Klichinsky Michael Chief Scientific Officer | 238,000 | $0 | 238,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:13 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | Ugwumba Chidozie Director | 38,700 | $0 | 38,700 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:11 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | Morrison Briggs Director | 38,700 | $0 | 38,700 (Direct) | View |
Ownership | 2023-03-13 5:06 pm | N/A N/A | Carisma Therapeutics Inc. | CARM | ModernaTX Inc. 10% Owner | 0 | $0 | 5,059,338 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 9:32 pm | N/A 2028-09-18 | Carisma Therapeutics Inc. | CARM | Kelly Steven President and CEO | 1,041,765 | $0 | 1,041,765 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 9:31 pm | N/A N/A | Carisma Therapeutics Inc. | CARM | Ugwumba Chidozie Director | 2,215,877 | $0 | 2,215,877 (Indirect) | View |
| 2023-03-07 Option Award | 2023-03-09 9:29 pm | N/A N/A | Carisma Therapeutics Inc. | CARM | Hodits Regina Director | 2,297,546 | $0 | 2,297,546 (Indirect) | View |
| 2023-03-07 Option Award | 2023-03-09 9:27 pm | N/A 2027-11-01 | Carisma Therapeutics Inc. | CARM | Klichinsky Michael Chief Scientific Officer | 729,369 | $0 | 729,369 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 9:26 pm | N/A 2031-05-31 | Carisma Therapeutics Inc. | CARM | Morris Richard Steven Chief Financial Officer | 331,114 | $0 | 331,114 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 9:25 pm | N/A N/A | Carisma Therapeutics Inc. | CARM | Torok Michael Director | 421,241 | $0 | 101,250 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 9:23 pm | N/A 2031-11-08 | Carisma Therapeutics Inc. | CARM | ZWEIFACH SANFORD S Director | 185,034 | $0 | 185,034 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 9:21 pm | N/A 2030-07-23 | Carisma Therapeutics Inc. | CARM | Morrison Briggs Director | 109,674 | $0 | 109,674 (Direct) | View |
| 2023-03-02 Exercise | 2023-03-06 8:46 pm | N/A N/A | Sesen Bio Inc. | SESN | Sullivan Mark General Counsel & Secretary | 298,175 | $0.587 | 378,651 (Direct) | View |
| 2023-03-02 Exercise | 2023-03-06 8:45 pm | N/A N/A | Sesen Bio Inc. | SESN | MacDonald Glen C Chief Technology Officer | 286,292 | $0.587 | 398,918 (Direct) | View |
| 2023-03-02 Exercise | 2023-03-06 8:43 pm | N/A N/A | Sesen Bio Inc. | SESN | Cannell Thomas R President and CEO | 606,800 | $0.587 | 672,386 (Direct) | View |
| 2023-03-02 Exercise | 2023-03-06 8:41 pm | N/A N/A | Sesen Bio Inc. | SESN | Forbes Monica Chief Financial Officer | 371,125 | $0.587 | 505,664 (Direct) | View |